HC Wainwright & Co. Maintains Buy on ACADIA Pharmaceuticals, Raises Price Target to $37

Benzinga · 1d ago
HC Wainwright & Co. analyst Ananda Ghosh maintains ACADIA Pharmaceuticals (NASDAQ:ACAD) with a Buy and raises the price target from $32 to $37.